Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. - Wikidata - wikimedia - TriplyDB

Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

http://www.wikidata.org/entity/Q37431696

about

Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors Visuocortical function in infants with a history of neonatal jaundice.Evaluating risks for vigabatrin treatment Infantile spasms: a U.S. consensus report.Vigabatrin monotherapy for infantile spasms.Contributing factors to VEP grating acuity deficit and inter-ocular acuity difference in children with cerebral visual impairment.Perceptual learning leads to long lasting visual improvement in patients with central vision loss.West Syndrome: A Review and Guide for Paediatricians.Electroretinographic (ERG) responses in pediatric patients using vigabatrin.

P2860

Q28483144-DE1132AF-B4DC-4230-8E49-E9C68CCDF816 Q34341850-993F5028-4509-444A-9823-F193F97F703A Q37380373-B339542F-2E78-4734-B7F2-857B8ADE0D6B Q37770587-48EE8E0E-50B0-42C6-BC3E-50EF5141BAC3 Q37987986-1205B3E6-B548-4352-BDF0-CDC9A0F8D89A Q44164330-CC7A53C9-DC64-43BE-9400-EFA860FA5A76 Q46395607-1951B4D2-EC64-4584-8E64-46691EB0A1EA Q47993800-57891BF8-616A-44BF-A414-7C00D59CECEE Q48009148-6B0950F6-E475-4A2B-9176-EAB09F605DC4

P2860

Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy.

http://www.wikidata.org/entity/Q37431696

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@en

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@nl

type

label

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@en

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@nl

prefLabel

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@en

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@nl

P1433

Q37431696-54AC66CA-1CC0-4B26-9720-88860A22C68E

P1476

Q37431696-A73989F9-8254-4692-92E9-EE416C5D2F78

P2093

Q37431696-384470E8-01F6-4953-A915-58F534D25BFB

Q37431696-8C1852F3-4C89-465C-B252-967CB411EBA9

Q37431696-9AFAB3B9-0C16-4216-B12E-94931113502D

Q37431696-F1E03F43-EEB0-487B-A18E-4A3A9D221F5F

P2860

Q37431696-02130022-CADF-4171-8CCE-5B8009177DF4

Q37431696-2207DDE9-8D0D-4B51-AE96-0B8808AAFD5E

Q37431696-288E8955-E17F-4690-A77B-8F5E2B1B02C8

Q37431696-2DC19D7E-579E-4145-8D05-453D53F7F2FD

Q37431696-34934EA6-1AD9-4032-983D-1EF43FB26A7F

Q37431696-3BD085CA-2A69-4927-A949-46C8DC71DFF1

Q37431696-40AFCF14-E78E-4111-9066-83FD744A6EC6

Q37431696-42379D0A-4D4E-454C-B2DD-461A7C600091

Q37431696-4BD08B90-B9A7-4224-873C-8C8063BCE410

Q37431696-4DF1B1E1-6274-4D4B-B3FF-AB97DAE9DF59

P304

Q37431696-E087F8F0-2027-4DC1-B963-602E5572C1B3

P31

Q37431696-2235F50E-F57C-4C52-8F11-ACDA4A3AE4AE

P356

Q37431696-B7E55BF0-881F-425C-AAB3-F941445CFD42

P407

Q37431696-159E942A-BC14-484C-8178-F3CC8EA58511

P433

Q37431696-D43B5646-0C11-427C-BD50-8FE0C4580272

P478

Q37431696-BD937FC1-E6A9-4DA5-A495-130B0BC6E1FB

P577

Q37431696-3C0C4269-7922-43E2-885C-2A32A8ADF884

P698

Q37431696-24BB2CA2-0BBB-47A2-8AF4-6020377E20B5

P932

Q37431696-3186A66E-8E61-48D7-995F-7CC540B7E3D0

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Reduced grating acuity associa ...... spasms on vigabatrin therapy.

@en

P2093

Carol A Westall

http://www.w3.org/2001/XMLSchema#string

Giuseppe Mirabella

http://www.w3.org/2001/XMLSchema#string

J Raymond Buncic

http://www.w3.org/2001/XMLSchema#string

Sivan Durbin

http://www.w3.org/2001/XMLSchema#string

P2860

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

Characteristics of a unique visual field defect attributed to vigabatrin

Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Visual field loss associated with vigabatrin: quantification and relation to dosage.

Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.

Characterization of vigabatrin-associated optic atrophy.

Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children

Electrophysiological assessment of contrast sensitivity in human infants.

Spatial frequency sweep VEP: visual acuity during the first year of life.

Infant VEP acuity measurements: analysis of individual differences and measurement error.

P304

4011-4016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.08-3237

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19279311

http://www.w3.org/2001/XMLSchema#string

P932

3880356

http://www.w3.org/2001/XMLSchema#string